Position in CDXS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,574,313
+$1,179,927 QoQ
Shares Held
696,599
+187.9% QoQ
Ownership
0.636%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 148 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. CDXS ranks #181 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in CDXS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,574,313 | 696,599 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $394,386 | 241,955 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $64,880 | 39,804 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $55,497 | 22,745 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $82,101 | 33,648 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $88,522 | 32,908 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,255,549 | 263,218 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $791,008 | 256,821 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,038,190 | 334,900 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,855,905 | 531,778 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,781,166 | 583,989 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,299,979 | 687,820 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,197,462 | 1,141,951 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,119,047 | 994,939 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,748,064 | 1,018,898 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,226,147 | 697,384 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,871,783 | 561,356 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,812,884 | 427,395 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $20,670,595 | 661,036 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,984,326 | 300,272 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,106,207 | 357,732 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,282,357 | 361,833 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,482,354 | 113,713 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $503,998 | 42,930 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $977,219 | 85,721 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||